Malacañang has addressed public concern on the increase of reported COVID-19 cases in the country for the past two days.
Presidential Spokesperson Harry Roque said that based on the explanation of the Department of Health (DOH), a large percentage of the new data are from backlogs and are not fresh cases.
Roque also made it clear that the use of Fabunan antiviral injections has not yet been approved.
“Importante po kasi na bago maibigay sa publiko ang kahit anong gamot, kasama na po diyan ang Fabunan, ay rehistrado sa FDA (It is necessary that before any medicine is prescribed to the public, including Fabunan, it must be registered with the FDA),” he explained.
“At ngayon po, mayroong cease and desist order ang Fabunan galing po sa FDA, kasi wala pa pong tinatawag na clinical studies (There is now a cease and desist order on Fabunan from the FDA because there are no clinical studies yet),” he added.
